Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis †

ORCID
0000-0002-1420-7366
Zugehörigkeit
Department of Head and Neck Oncology, All India Institute of Medical Sciences, Raipur 492099, India;
Rao, Karthik Nagaraja;
ORCID
0000-0001-9989-5534
Zugehörigkeit
Department of Head Neck Surgery, Tata Memorial Hospital, Mumbai 400012, India;
Pai, Prathamesh S.;
ORCID
0000-0002-1952-4061
Zugehörigkeit
Department of Head and Neck Oncology, All India Institute of Medical Sciences, Raipur 492099, India;
Dange, Prajwal;
ORCID
0000-0002-0481-156X
Zugehörigkeit
Department of Head and Neck Surgery and Otorhinolaringology, A.C. Camargo Cancer Center, São Paulo 01509, Brazil;
Kowalski, Luiz P.;
ORCID
0000-0002-0445-112X
Zugehörigkeit
Department of Radiation Oncology, Institute of Oncology Ljubljana, Faculty of Medicine, SI-10000 Ljubljana, Slovenia;
Strojan, Primož;
ORCID
0000-0002-0451-2404
Zugehörigkeit
Research Program in Systems Oncology, Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, Helsinki University Hospital, University of Helsinki, 00014 Helsinki, Finland;
Mäkitie, Antti A.;
GND
1078441464
ORCID
0000-0001-9671-0784
Zugehörigkeit
Department of Otorhinolaryngology, Jena University Hospital, 07747 Jena, Germany;
Guntinas-Lichius, Orlando;
ORCID
0000-0002-3255-8960
Zugehörigkeit
Department of Otolaryngology Head and Neck Surgery, Southern Illinois University, Carbondale, IL 62901, USA;
Robbins, K. Thomas;
ORCID
0000-0003-3063-0890
Zugehörigkeit
Department of Otolaryngology, Hospital Universitario Central de Asturias-Instituto de Salud del Principado de Asturias (ISPA), 33011 Oviedo, Spain;(J.P.R.);(A.C.-P.);(F.L.)
Rodrigo, Juan P.;
Zugehörigkeit
Department of Radiation Oncology, University of Michigan Medicine, Ann Arbor, MI 48109, USA;
Eisbruch, Avraham;
ORCID
0000-0003-4784-0499
Zugehörigkeit
Department of Otorhinolaryngology and Head and Neck Surgery, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands;
Takes, Robert P.;
ORCID
0000-0001-7128-5814
Zugehörigkeit
Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands;
de Bree, Remco;
ORCID
0000-0003-1363-8559
Zugehörigkeit
Department of Otolaryngology, Hospital Universitario Central de Asturias-Instituto de Salud del Principado de Asturias (ISPA), 33011 Oviedo, Spain;(J.P.R.);(A.C.-P.);(F.L.)
Coca-Pelaz, Andrés;
ORCID
0000-0002-2391-9357
Zugehörigkeit
Otorhinolaryngology—Head and Neck Surgery, ASST Spedali Civili di Brescia, School of Medicine, University of Brescia, 25121 Brescia, Italy;
Piazza, Cesare;
ORCID
0000-0001-9454-9464
Zugehörigkeit
Otorhinolaryngology—Head & Neck Surgery, Donostia University Hospital, 20014 Donostia, Spain;
Chiesa-Estomba, Carlos;
ORCID
0000-0001-7019-9746
Zugehörigkeit
Department of Otolaryngology, Hospital Universitario Central de Asturias-Instituto de Salud del Principado de Asturias (ISPA), 33011 Oviedo, Spain;(J.P.R.);(A.C.-P.);(F.L.)
López, Fernando;
ORCID
0000-0003-4972-1477
Zugehörigkeit
Department of Hematology and Medical Oncology, The Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA;
Saba, Nabil F.;
ORCID
0000-0001-7956-6709
Zugehörigkeit
ENT Unit, Policlinico Città di Udine, 33100 Udine, Italy;
Rinaldo, Alessandra;
ORCID
0000-0002-8247-8002
Zugehörigkeit
Coordinator of the International Head and Neck Scientific Group, 35100 Padua, Italy;
Ferlito, Alfio

Background: The management of cT3 laryngeal cancers remains controversial, with studies recommending surgical or non-surgical approaches. Despite the many papers that have been published on the subject, there is a lack of studies showing which treatment has better results in terms of survival. Objective: To determine the difference in survival outcomes following total laryngectomy (TL), concurrent chemoradiation (CRT) or radiation therapy (RT) alone in T3 laryngeal cancers. Methods: Search of PubMed, Scopus, and Google Scholar databases from 1995 to 2023 employing specific keywords and Boolean operators to retrieve relevant articles. Statistical analysis was conducted using a random-effects model, and heterogeneity was evaluated using the Q-test and I 2 statistic. Funnel plot asymmetry was assessed using rank correlation and regression tests. Results: The qualitative data synthesis comprised 10,940 patients from 16 included studies. TL was performed in 2149 (19.4%), CRT in 6723 (61.5%), RT in 295 (2.7%), while non-surgical treatment was not specified in 1773 (16.2%) patients. The pooled 2-year overall survival (OS) rates were TL = 73%, CRT = 74.7%, RT = 57.9%, 3-year OS rates were TL = 64.3%, CRT = 62.9%, RT = 52.4%, and 5-year OS rates were TL = 54.2%, CRT = 52.7%, RT = 40.8%. There was a significant heterogeneity in the included studies. There was no statistically significant difference in 2-year OS (logOR= −0.88 (95% confidence interval (CI): −1.99 to 0.23), p = 0.12), 3-year OS (logOR = −0.6 (95% CI: −1.34 to 0.15), p = 0.11), and 5-year OS (logOR = −0.54 (95% CI: −1.29 to 0.21), p = 0.16) between TL and CRT. Instead, there was significant difference in 2-year OS (logOR= −1.2383 (95% CI: −2.1679 to −0.3087), p = 0.009), 3-year OS (−1.1262 (95% CI: −1.6166 to −0.6358), p < 0.001), and 5-year OS (−0.99 (95% CI: −1.44 to −0.53)), p < 0.001) between TL and RT alone. Conclusions and Significance: TL followed with adjuvant (chemo)radiation on indication and CRT with salvage surgery in reserve appear to have similar OS outcomes. Both resulted in better OS outcomes compared to RT alone in the treatment of T3 laryngeal cancers. If patients are unfit for chemotherapy, making CRT impossible, surgery may become the choice of treatment.

Zitieren

Zitierform:
Zitierform konnte nicht geladen werden.

Rechte

Rechteinhaber: © 2023 by the authors.

Nutzung und Vervielfältigung: